The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.


Neptune Technologies & Bioressources Inc

Delayed quote


Today's change0.00 0.00%
Updated January 1 -- EDT. Delayed by at least 15 minutes.

Neptune Technologies & Bioressources Inc unchanged

Neptune Technologies & Bioressources Inc is unchanged Thursday sitting at $1.70. Over the last five days, shares have gained 2.41%, but are down 22.73% for the last year to date. Shares have underperformed the S&P TSX by 38.22% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.25
Updated January 1 -- EDT. Delayed by at least 15 minutes.


Net Profit (TTM)

Although this company's net profit margin is negative, it is above the industry average and implies that Neptune Technologies & Bioressources Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedNov 30, 201411/30/2014Aug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014
Total other revenue--------
Total revenue5344
Gross profit0-411
Total cost of revenue4733
Total operating expense1117125
Selling / general / administrative47810
Research & development3322
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)------1
Other operating expenses, total00-2-11
Operating income-6-14-8-1
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax0-15-4-1
Income after tax0-15-4-1
Income tax, total0000
Net income-1-13-50
Total adjustments to net income--------
Net income before extra. items-1-13-50
Minority interest-1202
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-13-50
Inc. avail. to common incl. extra. items-1-13-50
Diluted net income-1-13-50
Dilution adjustment--000
Diluted weighted average shares75757361
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.17-0.060.00
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share-0.02-0.17-0.060.03